Veru Announces the Sale of the FC2 Female Condom® (Internal …

Veru Inc. Sells FC2 Female Condom Business For $18 Million To …

2 weeks from now

Dec 31, 2024  · Veru Inc. has sold its FC2 Female Condom business for $18 million to Riva Ridge Capital Management and other co-investors, allowing the company to concentrate on its …

nasdaq.com

Veru Sells FC2 Condom Business For $18 Million, Focuses On …

2 weeks from now

Dec 31, 2024  · Veru Inc. (NASDAQ:VERU) shares jumped on Tuesday after the company disclosed the sale of its FC2 Female Condom (Internal Condom) business to clients managed …

yahoo.com

Veru Announces The Sale Of The FC2 Female Condom® (Internal

2 weeks from now

Dec 31, 2024  · As a result of the sale of the FC2 business, including the transfer of its UK and Malaysian based subsidiaries, Veru’s headcount will be reduced by approximately 90% from …

globenewswire.com

Veru Sells FC2 Condom Business For $18 Million, Focuses On …

2 weeks from now

Dec 31, 2024  · Veru sells its FC2 Female Condom business for $18M, shrinking its workforce by 90%, and refocusing on biopharma R&D. Proceeds will fund late-stage clinical trials, including …

benzinga.com

Veru Announces The Sale Of The FC2 Female Condom® (Internal …

2 weeks from now

Dec 31, 2024  · Veru Inc. Sells FC2 Business to Focus on Biopharma. ... Veru sells FC2 Female Condom business for $18M. TipRanks 9d. Analysts Are Bullish on These Healthcare Stocks: …

businessinsider.com

Veru Sells FC2 Female Condom Business For $18M, Shifts Focus To ...

2 weeks from now

Dec 31, 2024  · Veru Inc. (NASDAQ: VERU) has sold its FC2 Female Condom® business to clients managed by Riva Ridge Capital Management LP and co-investors for $18 million.The …

stocktitan.net

Veru Sells FC2 Female Condom Business For $18M - Markets Insider

2 weeks from now

Dec 31, 2024  · Veru has sold its FC2 Female Condom business to clients managed by Riva Ridge Capital Management as well as other co-investors, for $18M, subject to adjustment as …

businessinsider.com

Veru Inc. Completes Strategic Transition With $18 Million Deal

2 weeks from now

Dec 31, 2024  · With the completion of the sale of the FC2 Female Condom business, Veru Inc. is strategically positioning itself within the biopharmaceutical sector. The focus on developing …

investorshangout.com

Veru Inc. Sells FC2 Business To Focus On Biopharma

2 weeks from now

Jan 3, 2025  · Veru Inc. announced the sale of its FC2 Female Condom business to Clear Future, Inc. for $18 million. This divestment allows Veru to focus on its biopharmaceutical pursuits, …

businessinsider.com

Veru Sells Female Condom Business To Riva Ridge Capital For $18 …

2 weeks from now

Dec 31, 2024  · Veru Sells Female Condom Business to Riva Ridge Capital for $18 Million 09:13am: MT Veru Inc. Reports Earnings Results for the Full Year Ended September 30, 2024 …

marketscreener.com

Veru Announces The Sale Of The FC2 Female Condom® (Internal …

2 weeks from now

Dec 31, 2024  · As a result of the sale of the FC2 business, including the transfer of its UK and Malaysian based subsidiaries, Veru’s headcount will be reduced by approximately 90% from …

marketscreener.com

Veru Sells FC2 Female Condom Business For $18M - TipRanks

2 weeks from now

Veru sells FC2 Female Condom business for $18M - TipRanks

tipranks.com

Veru Surges As It Sells FC2 Female Condom Business To Private

2 weeks from now

Veru has sold its FC2 female condom business for $18M to a group of private investors. The buyers include clients of Riva Ridge Capital Management. As a result, Veru's employee …

msn.com

Veru To Lay Off Jobs After Sale Of Female Condom Business - South ...

2 weeks from now

Dec 31, 2024  · The Miami company sold its female condom business to an investment firm for $18 million. Veru sold its FC2 Female Condom business for $18 million. The sale reduces …

bizjournals.com

Veru Inc. Sells FC2 Female Condom Business For $18 Million To …

2 weeks from now

Dec 31, 2024  · Veru successfully sold its FC2 Female Condom® business for $18 million, allowing it to focus solely on its biopharmaceutical development efforts. The sale is expected …

quiverquant.com